Search research articles
Contact Us
Filters
Showing results (131-140 of 143) with videos related to
Page
of 15
Sort By:
The AAPS Journal
|
June 2, 2011
AAPS workshop report: strategies to address therapeutic protein-drug interactions during clinical development
Sandhya Girish, Steven W Martin, Mark C Peterson, et al.
Clinical and Translational Science
|
June 26, 2020
Early M-Protein Dynamics Predicts Progression-Free Survival in Patients With Relapsed/Refractory Multiple Myeloma
Xiaoyu Yan, Xu Steven Xu, Katja C Weisel, et al.
ACS Applied Materials & Interfaces
|
June 14, 2016
Two-Dimensional Layered Oxide Structures Tailored by Self-Assembled Layer Stacking via Interfacial Strain
Wenrui Zhang, Mingtao Li, Aiping Chen, et al.
Advances in Therapy
|
February 21, 2020
Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses
Xu Steven Xu, Philippe Moreau, Saad Z Usmani, et al.
Journal of Clinical Pharmacology
|
November 4, 2020
Exposure-Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients
Man Melody Luo, Saad Z Usmani, Maria-Victoria Mateos, et al.
Journal of Clinical Pharmacology
|
October 28, 2021
Population Pharmacokinetics and Exposure-Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light-Chain Amyloidosis
Man Melody Luo, Peijuan Penny Zhu, Ivo Nnane, et al.
Clinical Pharmacology in Drug Development
|
May 1, 2023
A Phase 1 First-in-Human Pharmacokinetic and Pharmacodynamic Study of JNJ-64264681, a Covalent Inhibitor of Bruton's Tyrosine Kinase
Jocelyn H Leu, Xin Miao, Kevin Shalayda, et al.
Journal of Clinical Pharmacology
|
February 27, 2007
Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis
Honghui Zhou, Haishan Jang, Roy M Fleischmann, et al.
Journal of Affective Disorders
|
September 3, 2024
Psychosocial functioning and its influencing factors in patients with depression post-remission: Implications for assessment and interventions
Hao Yang, Mengjiao Wu, Wenyan Huang, et al.
The AAPS Journal
|
March 15, 2025
Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report
Sophie Shubow, Michele Gunsior, Amy Rosenberg, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 143) with videos related to
Sort By:
Page
of 15
The AAPS Journal
|
June 2, 2011
AAPS workshop report: strategies to address therapeutic protein-drug interactions during clinical development
Sandhya Girish, Steven W Martin, Mark C Peterson, et al.
Clinical and Translational Science
|
June 26, 2020
Early M-Protein Dynamics Predicts Progression-Free Survival in Patients With Relapsed/Refractory Multiple Myeloma
Xiaoyu Yan, Xu Steven Xu, Katja C Weisel, et al.
ACS Applied Materials & Interfaces
|
June 14, 2016
Two-Dimensional Layered Oxide Structures Tailored by Self-Assembled Layer Stacking via Interfacial Strain
Wenrui Zhang, Mingtao Li, Aiping Chen, et al.
Advances in Therapy
|
February 21, 2020
Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses
Xu Steven Xu, Philippe Moreau, Saad Z Usmani, et al.
Journal of Clinical Pharmacology
|
November 4, 2020
Exposure-Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients
Man Melody Luo, Saad Z Usmani, Maria-Victoria Mateos, et al.
Journal of Clinical Pharmacology
|
October 28, 2021
Population Pharmacokinetics and Exposure-Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light-Chain Amyloidosis
Man Melody Luo, Peijuan Penny Zhu, Ivo Nnane, et al.
Clinical Pharmacology in Drug Development
|
May 1, 2023
A Phase 1 First-in-Human Pharmacokinetic and Pharmacodynamic Study of JNJ-64264681, a Covalent Inhibitor of Bruton's Tyrosine Kinase
Jocelyn H Leu, Xin Miao, Kevin Shalayda, et al.
Journal of Clinical Pharmacology
|
February 27, 2007
Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis
Honghui Zhou, Haishan Jang, Roy M Fleischmann, et al.
Journal of Affective Disorders
|
September 3, 2024
Psychosocial functioning and its influencing factors in patients with depression post-remission: Implications for assessment and interventions
Hao Yang, Mengjiao Wu, Wenyan Huang, et al.
The AAPS Journal
|
March 15, 2025
Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report
Sophie Shubow, Michele Gunsior, Amy Rosenberg, et al.
Page
of 15